adagrasib for previously treated kras g12c nsclc - asco lung review 2022
Published 1 year ago • 371 plays • Length 12:25Download video MP4
Download video MP3
Similar videos
-
4:13
sotorasib vs. adagrasib as treatment for kras g12c mutated nsclc - case based panel discussion
-
5:46
patritumab deruxtecan: use in previously treated patients without mutations - asco lung review 2022
-
5:26
asco 2021 lung recap: codebreak 100: sotorasib in kras g12c mutation
-
2:40
krystal 7 study: adagrasib /- pembrolizumab for kras g12c nsclc -targeted therapies in lung cancer
-
6:09
adagrasib – mechanism of action and synthesis
-
44:57
codebreak 200 | sotorasib | a negligent trial that violated randomization!
-
5:20
opción de tratamiento kras: adagrasib - cáncer de pulmón 2023
-
7:39
chemotherapy and immunotherapy for patients with kras mutations - asco lung review 2022
-
7:44
treatment for kras g12c mutated nsclc with high tumor mutational burden -case-based panel discussion
-
7:54
keytruda combined with anti-vegf treatment:use in patients with advanced nsclc-asco lung review 2022
-
3:56
kras g12c inhibitors versus chemotherapy in second line - targeted therapies in lung cancer 2023
-
8:35
asco lung cancer roundtable - nsclc - the cityscape trial: anti tigit & immune checkpoint inhibitor
-
6:38
asco 2021 lung recap: poseidon trial: durvalumab /- tremelimumab vs. chemo alone
-
8:13
checkmate 816: combining chemo and opdivo - asco lung review 2022
-
8:08
asco 2021 lung recap: mylung consortium: overall biomarker testing
-
2:45
kras mutations in advanced nsclc - 2022 program: targeted therapies forum - english
-
4:04
challenges of targeted kras treatment & current treatments - targeted therapies in lung cancer 2023
-
5:11
gracecast-114_lung-cancer_asco 2012 lc highlights: dr. neal on mek inhibitor selumetinib in nsclc
-
11:58
asco lung cancer roundtable - mesothelioma updates
-
5:35
progression on sotorasib with kras nsclc - 2022 program: targeted therapies forum
-
7:44
asco lung cancer highlights, part 1: introduction to stage iii nsclc